Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION AND EMPLOYEE BENEFIT PLAN

v3.19.1
STOCK-BASED COMPENSATION AND EMPLOYEE BENEFIT PLAN
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION AND EMPLOYEE BENEFIT PLAN

NOTE 16 – STOCK-BASED COMPENSATION AND EMPLOYEE BENEFIT PLAN

 

Except as noted below, we do not have a qualified stock option plan, but have issued stock purchase warrants and stock options on a discretionary basis to employees, directors, service providers, private placement participants and outside consultants.

 

The Company utilizes ASC 718, Stock Compensation, related to accounting for share-based payments and, accordingly, records compensation expense for share-based awards based upon an assessment of the grant date fair value for stock options and restricted stock awards. The Black Scholes option pricing model was used to estimate the fair value of the options granted. This option pricing model requires a number of assumptions, of which the most significant are: expected stock price volatility, the expected pre-vesting forfeiture rate, and the expected option term (the amount of time from the grant date until the options are exercised or expire). The Company estimated a volatility factor utilizing a weighted average of comparable published volatilities. The Company applied the simplified method to determine the expected term of all stock-based compensation grants. The risk free interest rate is based on or approximates the U.S. Treasury yield curve in effect at the time of the grant.

 

Stock compensation expense for stock options is recognized on a straight-line basis over the vesting period of the award. The Company accounts for stock options as equity awards.

 

Share-based compensation expense recognized in the statements of operations is based on awards ultimately expected to vest, which considers estimated forfeitures. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company recognizes the expense or benefit from the effect of adjusting the estimated forfeiture rate in the period that the forfeiture estimates changes.

 

The weighted average estimated fair value of stock option grants and the weighted average assumptions that were used in calculating such values for the years ended December 31, 2018 and 2017 are as follows:

 

    2018     2017  
             
Risk-free interest rate           1.84-1.89%  
Expected volatility           36.87-39.17%  
Expected life (in years)           4.5-5.5  
Dividend rate           0  
Weighted-average estimated fair value per award           $.17  

 

For the years ended December 31, 2018 and 2017, we recorded stock-based compensation awarded to employees of $101,400 and $131,600, respectively, which is included in selling, general and administrative expense in our consolidated statements of operations.

 

A summary of stock option activity for the year ended December 31, 2018 is presented as follows:

 

                Weighted     Weighted  
          Weighted     Average     Average  
    Number     Average     Remaining     Grant  
    Of     Exercise     Contractual     Date  
    Shares     Price     Life     Fair Value  
                         
Outstanding at January 1, 2018     2,135,000     $ .85       8.3 years     $ .17  
Granted                          
Exercised                          
Forfeited/expired/canceled     (1,385,000 )   $ .92             $ .14  
Outstanding at December 31, 2018     750,000     $ .72       1.2 years     $ .24  
Vested and exercisable at December 31, 2018     736,700     $ .72       0 years     $ .24  

 

A summary of stock option activity for the year ended December 31, 2017 is presented as follows:

 

                Weighted     Weighted  
          Weighted     Average     Average  
    Number     Average     Remaining     Grant  
    Of     Exercise     Contractual     Date  
    Shares     Price     Life     Fair Value  
                         
Outstanding at January 1, 2017     865,000     $ .89       2.7 years     $ .40  
Granted     2,000,000     $ .85             $ .17  
Exercised     (200,000 )   $ .72             $ .23  
Forfeited/expired/canceled     (530,000 )   $ .98             $ .49  
Outstanding at December 31, 2017     2,135,000     $ .85       8.3 years     $ .17  
Vested and exercisable at December 31, 2017     687,500     $ .86       .38 years     $ .18  

 

As of December 31, 2018, there was approximately $1,100 of total unrecognized compensation cost related to non-vested stock options that is expected to be recognized over a weighted-average period of approximately six months. The intrinsic value of vested options outstanding as of December 31, 2018 was $53,042.

 

Employee Benefit Plan

 

We have a defined contribution 401(k) plan that covers substantially all employees. Additionally, at the discretion of management, we may make contributions to eligible participants, as defined. During the years ended December 31, 2018 and 2017, we made contributions of $0 in each year.